Rare diseases
Investigational molecules
Locations
22 Boston Wharf Road, Floor 10, 02210, United States
Astria Therapeutics Inc. focuses its clinical research on hereditary angioedema, with studies spanning both Type 1 and Type 2 HAE. The programme centers on preventing attacks and evaluating treatment options for people living with this rare disease.
The sponsor’s current trial portfolio includes multiple active studies across several countries, with research sites supporting the clinical evaluation of HAE in both long-term and preventive care settings.
Astria Therapeutics Inc. runs clinical trials in conditions such as Hereditary angioedema with C1 esterase inhibitor deficiency, Hereditary angioedema, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
BulgariaBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
